StockWatch
·
Other Pharmaceuticals
Loan & DebtAug 5, 2026, 06:51 AM

Cencora Increases Revolving Credit Facility to $7.0B

AI Summary

Cencora, Inc. and its subsidiary Innomar Strategies Inc. entered into an Amended and Restated Credit Agreement on July 31, 2026, significantly increasing their multi-currency revolving credit facility from $5.5 billion to $7.0 billion and extending its maturity to July 2031. Concurrently, the company amended its receivables securitization facility, decreasing its size from $1.5 billion to $1.0 billion but enhancing its accordion feature from $500 million to $1.0 billion, allowing for potential future increases. These actions aim to provide additional liquidity and funding for ongoing business needs.

Key Highlights

  • Increased multi-currency revolving credit facility from $5.5 billion to $7.0 billion.
  • Extended the revolving credit facility's maturity date to July 2031.
  • Adjusted interest rates for the revolving credit facility based on public debt ratings.
  • Amended receivables securitization facility, adding a new uncommitted purchaser.
  • Decreased receivables securitization facility from $1.5 billion to $1.0 billion.
  • Increased receivables securitization facility's accordion feature from $500 million to $1.0 billion.
  • Aligned financial covenants in the performance undertaking with the credit agreement.